SCHEMBL7709567

SCHEMBL7709567

CCCCCC(O)Oc1ccc(-c2nc(-c3ccc(C)cc3C)nc(-c3ccc(C)cc3C)n2)c(O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.36
NPC1 O15118 3/20 0.35
CNR1 P21554 2/20 0.34
CNR2 P34972 2/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 3/20 0.33
PLK1 P53350 3/20 0.33
MAPT P10636 2/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16107212 0.90 PLK1 (0.36) TLR8CNR1CNR2LMNAPLK1
SCHEMBL10253638 0.88 CNR1 (0.36) TLR8NPC1CNR1CNR2TP53
SCHEMBL1068828 0.88 TLR8 (0.35) TLR8NPC1CNR1CNR2TP53
SCHEMBL30575191 0.87 CNR1 (0.34) TLR8NPC1CNR1CNR2TP53
SCHEMBL13366375 0.85 NPC1 (0.39) NPC1RAB9ALMNAMAPTALDH1A1
SCHEMBL26629793 0.85 ALDH2 (0.47) SMN1; SMN2PLK1ALDH2
SCHEMBL8387404 0.84 NR5A1 (0.39) CNR2TP53TSHR
SCHEMBL15854557 0.84 LMNA (0.36) TLR8NPC1TP53POLBNFKB1
SCHEMBL5081652 0.84 CNR2 (0.32) TLR8NPC1CNR1CNR2TP53
SCHEMBL14480246 0.84 PLA2G4B (0.39) TLR8NPC1CNR1CNR2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355708-B2 USEFUL IN STABILIZING POLYMERS AND OTHER MATERIALS FROM DEGRADATION BY ENVIRONMENTAL FORCES SUCH AS ACTINIC RADIATION (ULTRAVIOLET LIGHT), OXIDATION, MOISTURE, ATMOSPHERIC POLLUTANTS CIBA SPECIALTY CHEMICALS CORPORATION 2002-03-12 US disclosed
US-20010031866-A1 Novel trisaryl-1,3,5-triazine ultraviolet light absorbers GUPTA RAM BABOO (US) 2001-10-18 US disclosed
US-6242597-B1 STABILIZERS WITH A BONDABLE GROUP HAVING AN ACTIVE (ACIDIC) HYDROGEN; MIGRATION BETWEEN POLYMER LAYERS IS REDUCED CIBA SPECIALTY CHEMICALS CORPORATION 2001-06-05 US disclosed
EP-1032563-A1 TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CYTEC TECHNOLOGY CORP. (US) 2000-09-06 EP disclosed
WO-1999026934-A1 TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CYTEC TECHNOLOGY CORP. (US) 1999-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031866-A1 Novel trisaryl-1,3,5-triazine ultraviolet light absorbers ERCC5, XRCC5, ERCC1 TLR8 3657/4885NPC1 2328/4885CNR1 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.